Abstract 4368638: Comparable one-year efficacy and safety of spironolactone versus amiloride in resistant hypertension: A Retrospective Cohort Analysis

Authors

Mohamed Elgendy
Abdalhakim Shubietah, Advocate Health - MidwestFollow
Ahmed Emara
et al

Recommended Citation

Elgendy M, Shubietah A, Emara A, et al. Abstract 4368638: Comparable One-Year Efficacy and Safety of Spironolactone Versus Amiloride in Resistant Hypertension: A Retrospective Cohort Analysis. Circulation. 2025;152(Suppl_3):A4368638-A4368638. doi:10.1161/circ.152.suppl_3.4368638

Affiliations

Advocate Illinois Masonic Medical Center

Type

Abstract